Gossamer Bio (GOSS) Cash & Current Investments: 2022-2025
Historic Cash & Current Investments for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $180.2 million.
- Gossamer Bio's Cash & Current Investments fell 44.89% to $180.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $945.6 million, marking a year-over-year decrease of 22.64%. This contributed to the annual value of $294.5 million for FY2024, which is 0.64% down from last year.
- Gossamer Bio's Cash & Current Investments amounted to $180.2 million in Q3 2025, which was down 15.36% from $212.9 million recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's Cash & Current Investments registered a high of $354.5 million during Q2 2024, and its lowest value of $162.1 million during Q2 2023.
- Its 3-year average for Cash & Current Investments is $260.1 million, with a median of $257.9 million in 2025.
- As far as peak fluctuations go, Gossamer Bio's Cash & Current Investments soared by 118.65% in 2024, and later slumped by 44.89% in 2025.
- Quarterly analysis of 4 years shows Gossamer Bio's Cash & Current Investments stood at $255.7 million in 2022, then climbed by 15.94% to $296.4 million in 2023, then fell by 0.64% to $294.5 million in 2024, then plummeted by 44.89% to $180.2 million in 2025.
- Its Cash & Current Investments stands at $180.2 million for Q3 2025, versus $212.9 million for Q2 2025 and $257.9 million for Q1 2025.